These signals activate DCs through pattern recognition receptors (PRRs, including toll-like receptors or TLRs), leading to DC maturation and the cross-presentation of tumor-associated antigens (TAAs) on MHC class I and II molecules [99,100]. This evidence concerns the gene HLA-C and neoplasm.